These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30342538)

  • 21. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis.
    Du X; Li XQ; Li L; Xu YY; Feng YM
    Breast Cancer Res Treat; 2013 Feb; 138(1):59-67. PubMed ID: 23397283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.
    Chang JC; Makris A; Gutierrez MC; Hilsenbeck SG; Hackett JR; Jeong J; Liu ML; Baker J; Clark-Langone K; Baehner FL; Sexton K; Mohsin S; Gray T; Alvarez L; Chamness GC; Osborne CK; Shak S
    Breast Cancer Res Treat; 2008 Mar; 108(2):233-40. PubMed ID: 17468949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.
    Andres SA; Wittliff JL
    Endocrine; 2011 Oct; 40(2):212-21. PubMed ID: 21858728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of genes for normalization of real-time RT-PCR data in breast carcinomas.
    Lyng MB; Laenkholm AV; Pallisgaard N; Ditzel HJ
    BMC Cancer; 2008 Jan; 8():20. PubMed ID: 18211679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
    Nachmanson D; Steward J; Yao H; Officer A; Jeong E; O'Keefe TJ; Hasteh F; Jepsen K; Hirst GL; Esserman LJ; Borowsky AD; Harismendy O
    BMC Med Genomics; 2020 Nov; 13(1):173. PubMed ID: 33208147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression variation between distinct areas of breast cancer measured from paraffin-embedded tissue cores.
    Schobesberger M; Baltzer A; Oberli A; Kappeler A; Gugger M; Burger H; Jaggi R
    BMC Cancer; 2008 Nov; 8():343. PubMed ID: 19032762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ.
    Davis JE; Nemesure B; Mehmood S; Nayi V; Burke S; Brzostek SR; Singh M
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):20-5. PubMed ID: 26317313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
    Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
    Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.
    Müller BM; Kronenwett R; Hennig G; Euting H; Weber K; Bohmann K; Weichert W; Altmann G; Roth C; Winzer KJ; Kristiansen G; Petry C; Dietel M; Denkert C
    Diagn Mol Pathol; 2011 Mar; 20(1):1-10. PubMed ID: 21326033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer.
    Wang S; Li W; Liu N; Zhang F; Liu H; Liu F; Liu J; Zhang T; Niu Y
    J Cell Biochem; 2012 Jun; 113(6):1904-14. PubMed ID: 22234886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study.
    Drury S; Salter J; Baehner FL; Shak S; Dowsett M
    J Clin Pathol; 2010 Jun; 63(6):513-7. PubMed ID: 20498025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
    Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
    PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
    Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
    Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
    Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
    Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
    Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
    JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
    Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
    BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.
    Sánchez-Navarro I; Gámez-Pozo A; González-Barón M; Pinto-Marín A; Hardisson D; López R; Madero R; Cejas P; Mendiola M; Espinosa E; Vara JA
    Biotechniques; 2010 May; 48(5):389-97. PubMed ID: 20569212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.